PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,3-diphenylguanidine | 203-002-1 | 102-06-7 | 1 | - | 3 | - | 2 | 1 | - | - | - | Details |
| 1,3-diphenyl-2-thiourea | 203-004-2 | 102-08-9 | - | - | 3 | - | 1 | - | - | - | - | Details |
| 1,3-dioxolane | 211-463-5 | 646-06-0 | 1 | - | 3 | - | 2 | 1 | - | - | - | Details |
| 1,3-dioxepane | 208-015-6 | 505-65-7 | - | - | 3 | - | 1 | - | - | - | - | Details |
| 1,3-dimethylimidazolidin-2-one | 201-304-8 | 80-73-9 | - | - | 3 | - | - | 1 | - | - | - | Details |
| 1,3-diisopropylbenzene | 202-773-1 | 99-62-7 | 1 | - | 3 | - | 1 | - | - | - | - | Details |
| 1,3-Cyclohexanedimethanamine | 219-941-5 | 2579-20-6 | - | - | 3 | - | 1 | - | - | - | - | Details |
| 1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene | 423-300-7 | 911674-82-3 | - | - | 3 | - | - | - | - | - | - | Details |
| 1,3-bis(1-isocyanato-1-methylethyl)benzene | 220-474-4 | 2778-42-9 | - | - | 3 | - | 2 | 1 | - | - | - | Details |
| 1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione | 219-514-3 | 2451-62-9 | 1 | 1 | 3 | - | - | - | 1 | - | - | Details |